+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Office-based Labs Market, Competition, Forecast & Opportunities, 2028

  • PDF Icon

    Report

  • 90 Pages
  • October 2023
  • Region: United States
  • TechSci Research
  • ID: 5893515
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The United States Office-based Labs Market, valued at USD 9.81 Million in 2022, is expected to experience impressive growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 7.24% through 2028 and expected to reach USD 14.95 Million in 2028. In recent years, the United States healthcare industry has undergone a significant shift towards more accessible and patient-centric care. A key contributor to this transformation is the rise of office-based labs (OBLs), which are healthcare facilities located in outpatient settings, offering a range of medical procedures and diagnostics in a convenient and cost-effective manner.



The United States Office-based Labs Market has witnessed remarkable growth, driven by factors such as technological advancements, changes in the reimbursement landscape, and the increasing demand for efficient healthcare services. Office-based labs, also known as ambulatory surgery centers (ASCs) or outpatient facilities, provide various medical services outside the traditional hospital environment. These labs can perform diagnostic procedures, minor surgical interventions, and medical treatments that do not require a hospital stay. Services commonly offered in OBLs include endoscopy, cardiac catheterization, pain management procedures, and various imaging diagnostics.

OBLs aim to provide patients with a more convenient and efficient alternative to hospital-based care, allowing for quicker access to medical services and reduced costs. They offer a more accessible option for patients who require outpatient procedures, enabling easier appointment scheduling, shorter wait times, and a more comfortable recovery environment. OBLs also benefit from lower overhead costs compared to hospitals, potentially resulting in cost savings for both patients and payers. This is especially relevant in the context of the increasing focus on value-based care and cost containment.

Advances in medical technology have enabled the safe and effective performance of many complex procedures in outpatient settings. Minimally invasive techniques and improved imaging technologies have expanded the range of procedures that can be conducted in OBLs. Furthermore, recent shifts in reimbursement policies encourage the use of outpatient services for procedures that can be safely performed outside of a hospital.

Many OBLs are physician-owned and operated, allowing physicians to have greater control over their practice and patient care. This can lead to more personalized and patient-centered care experiences.

Key Market Drivers

1. Rising Patient Convenience and Accessibility: Patient convenience and accessibility are significant driving forces behind the growth of the United States Office-based Labs Market. These facilities offer a more patient-centric approach to healthcare, addressing the demand for convenient and efficient healthcare services. OBLs are strategically located for easier patient access, reducing travel time and improving the overall healthcare experience.

2. Rising Shift towards Outpatient Care: The United States is witnessing a shift towards outpatient care, driven by factors such as technological advancements, cost-effective care, patient preferences for convenience, and an emphasis on preventive healthcare. Patients are seeking high-quality medical care without the need for hospital stays, making OBLs a preferred choice for various procedures.

Key Market Challenges

1. Regulatory Hurdles: Navigating the complex regulatory landscape is a primary challenge for OBL operators. Compliance with federal and state regulations is essential, and staying updated with evolving requirements is critical for ongoing operations.

2. Reimbursement Issues: Receiving adequate reimbursement for services is a concern for OBLs. The complex billing and coding procedures can lead to payment delays or denials. Establishing fair reimbursement practices with payers is crucial.

3. Quality and Patient Safety: Maintaining high standards of quality and patient safety is paramount. OBLs must invest in state-of-the-art equipment, infection control protocols, and staff training to ensure quality care while upholding patient safety.

4. Competition and Market Saturation: The growing demand for OBL services has led to increased competition and the potential for market saturation. To stand out, OBLs must focus on building strong relationships with referring physicians, maintaining quality care, and offering unique services.

Key Market Trends

1. Technological Advancements: Rapid technological advancements are reshaping the OBL landscape. Minimally invasive procedures, telehealth solutions, remote patient monitoring, high-definition imaging, and collaborative technologies are enhancing patient care and driving innovation.

Segmental Insights

1. Modality: Hybrid OBLs, which offer a broader range of complex diagnostic and interventional procedures, dominate the market. These facilities combine advanced equipment and medical expertise to provide comprehensive medical care in a convenient outpatient setting.

2. Specialists: Interventional radiologists play a dominant role in the OBL market due to their extensive training and skills in medical imaging and image-guided procedures. They excel in interpreting imaging studies and performing precise, minimally invasive treatments.

Regional Insights

1. Midwest Region: The Midwest region, known for its expertise in imaging technology, innovation, skilled workforce, and investment resources, is likely to contribute significantly to innovation and technological advancements in the OBL sector. The presence of venture capital firms and funding opportunities can drive growth and innovation in the region.

Key Market Players

  • GE Healthcare
  • Siemens Healthineers AG
  • Medtronic PLC
  • Boston Scientific Corp.
  • Abbott
  • Cardiovascular Systems, Inc.
  • Koninklijke Philips N.V
  • GE Healthcare
  • Siemens Healthineers AG
  • Medtronic PLC
  • Boston Scientific Corp.
  • Abbott
  • Cardiovascular Systems, Inc.

Report Scope:

In this report, the United States Office-based Labs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Office-based Labs Market, By Modality:

  • Hybrid
  • Multi-specialty

Office-based Labs Market, By Service:

  • Peripheral vascular intervention
  • Endovascular intervention
  • Cardiac
  • Interventional radiology
  • Venous
  • Others

Office-based Labs Market, By Specialists:

  • Vascular surgeons
  • interventional cardiologists
  • interventional radiologists
  • Others

Office-based Labs Market, By Region:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Office-based Labs Market.

Available Customizations:

United States Office-based Labs Market report with the given market data, the publisher offers customizations according to a company's specific needs.



This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Office-based Labs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Modality (Hybrid, Multi-specialty)
5.2.2. By Service (peripheral vascular intervention, endovascular intervention, cardiac, interventional radiology, venous, and others)
5.2.3. By Specialists ( vascular surgeons, interventional cardiologists, interventional radiologists, and others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
6. Northeast United States Office-based Labs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Modality
6.2.2. By Service
6.2.3. By Specialists
7. Midwest United States Office-based Labs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Modality
7.2.2. By Specialists
8. West United States Office-based Labs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Modality
8.2.2. By Service
8.2.3. By Specialists
9. South United States Office-based Labs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Modality
9.2.2. By Service
9.2.3. By Specialists
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments12. United States Economic Profile13. PESTLE Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (In case of listed companies)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. GE Healthcare
15.6.2. Siemens Healthineers AG
15.6.3. Medtronic PLC
15.6.4. Boston Scientific Corp.
15.6.5. Abbott
15.6.6. Cardiovascular Systems, Inc.
15.6.7. Koninklijke Philips N.V
15.6.8. GE Healthcare
15.6.9. Siemens Healthineers AG
15.6.10. Medtronic PLC
15.6.11. Boston Scientific Corp.
15.6.12. Abbott
15.6.13. Cardiovascular Systems, Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • GE Healthcare
  • Siemens Healthineers AG
  • Medtronic PLC
  • Boston Scientific Corp.
  • Abbott
  • Cardiovascular Systems, Inc.
  • Koninklijke Philips N.V
  • GE Healthcare
  • Siemens Healthineers AG
  • Medtronic PLC
  • Boston Scientific Corp.
  • Abbott
  • Cardiovascular Systems, Inc.

Table Information